Regulation
PulseAI’s arrhythmia analysis model for wearables lands FDA clearance
PulseAI received FDA clearance for an AI model that analyzes ECG data from wearable devices to identify heart arrhythmias and assess stroke risk. The software processes data from compatible wearables and provides clinicians with arrhythmia detection insights.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network